DMK PHARMACEUTICALS Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was -$44.7K, a 160% decline year-over-year.
  • DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was -$249K.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2022 was -$340K, a 117% decline from 2021.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2021 was $2.02M.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2012 was $36.8K, a 89.9% decline from 2011.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$249K -$44.7K -$119K -160% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$130K $52.2K +$513K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$643K $69.3K -$303K -81.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$340K -$326K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $74.5K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$461K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $372K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q2 2013 $17.8K Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.